| Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587) | 
|---|
| 02/27/2014 | CA2876690A1 Dihydropyrimidine compounds and their application in pharmaceuticals | 
| 02/26/2014 | EP2699569A2 Aminopyrimidine kinase inhibitors | 
| 02/26/2014 | EP2699564A1 Substituted pyrimidinyl-pyrroles active as kinase inhibitors | 
| 02/26/2014 | EP2699563A1 Novel pesticidal pyrazole compounds | 
| 02/26/2014 | EP2699561A1 Androgen receptor modulating carboxamides | 
| 02/26/2014 | EP2699547A1 5-(phenyl/pyridinyl-ethinyl)-2-pyridine/ 2-pyrimidine-carborxamides as mglur5 modulators | 
| 02/26/2014 | EP2699545A1 Novel amino-pyrroline derivatives, and use thereof in the prevention and/or treatment of metabolic syndrome | 
| 02/26/2014 | CN103608343A Crystalline forms and processes for preparation of condensed azacycles (cannabinoid receptor modulators) | 
| 02/26/2014 | CN103608336A 9-[4-(3-chlor-2-fluor-phenylamino)-7-methoxy-quinazolin-6-yloxy]-1,4-diaza-spiro[5.5]undecan-5-one dimaleate, use thereof as a drug, and production thereof | 
| 02/26/2014 | CN103608335A Pyrimidine derivatives for the treatment of viral infections | 
| 02/26/2014 | CN103608333A 雄激素受体拮抗剂及其用途 Androgen receptor antagonists and their use | 
| 02/26/2014 | CN103601720A Solid salt forms of a pyrrole substituted 2-indolinone | 
| 02/26/2014 | CN103601684A 5-arylselenobenzimidazole compound and application thereof | 
| 02/26/2014 | CN102725283B Compounds and compositions as protein kinase inhibitors | 
| 02/26/2014 | CN102666530B Imatinib dichloroacetate and anti-cancer agent comprising the same | 
| 02/25/2014 | US8658654 Receptor-type kinase modulators and methods of use | 
| 02/25/2014 | US8658647 Integrin-linked kinase inhibitors | 
| 02/25/2014 | US8658635 Benzpyrazol derivatives as inhibitors of PI3 kinases | 
| 02/25/2014 | US8658207 Extended release tablet formulations of flibanserin and method for manufacturing the same | 
| 02/25/2014 | CA2777632C Imidazole derivatives as casein kinase inhibitors | 
| 02/25/2014 | CA2630410C 2,4,5-triphenyl imidazoline derivatives as inhibitors of the interaction between p53 and mdm2 proteins for use as anticancer agents | 
| 02/20/2014 | WO2014028801A1 Cyclopentylpyrazoles as n-type calcium channel blockers | 
| 02/20/2014 | WO2014028459A1 1,4-disubstituted pyridazine analogs and methods for treating smn-deficiency-related conditions | 
| 02/20/2014 | WO2014027814A1 Novel compound and organic electroluminescent device comprising same | 
| 02/20/2014 | WO2014027676A1 Organic electroluminescence element | 
| 02/20/2014 | WO2014027209A1 Pyrazolyl-ureas as kinase inhibitors | 
| 02/20/2014 | WO2014027053A1 Benzimidazoles for the treatment of cancer | 
| 02/20/2014 | WO2014026997A1 2,3-benzodiazepines | 
| 02/20/2014 | WO2014026880A1 Arylethynyl pyrimidines | 
| 02/20/2014 | WO2014026467A1 Bicyclic substituted pyrimidine compounds | 
| 02/20/2014 | WO2014026330A1 3-AMINOCYCLOALKYL COMPOUNDS AS RORgammaT INHIBITORS AND USES THEREOF | 
| 02/20/2014 | WO2014026329A1 N-alkylated indole and indazole compounds as rorgammat inhibitors and uses thereof | 
| 02/20/2014 | WO2014026328A1 3-cyclohexenyl substituted indole and indazole compounds as rorgammat inhibitors and uses thereof | 
| 02/20/2014 | WO2014026327A1 4-heteroaryl substituted benzoic acid compounds as rorgammat inhibitors and uses thereof | 
| 02/20/2014 | WO2014026243A1 Vegfr3 inhibitors | 
| 02/20/2014 | WO2014026242A1 Vegfr3 inhibitors | 
| 02/20/2014 | WO2013170068A3 Nuclear transport modulators and uses thereof | 
| 02/20/2014 | WO2012145617A9 Aminopyrimidine kinase inhibitors | 
| 02/20/2014 | WO2009021750A3 Benzoxazole, benzimidazole and benzothiazole derivatives and their use in the treatment of duchenne muscular dytrophy | 
| 02/20/2014 | US20140051863 Fluorescent probes for detection of copper | 
| 02/20/2014 | US20140051857 Heterocyclic compounds and thrombopoietin receptor activators | 
| 02/20/2014 | US20140051729 Compositions and methods for treating degenerative muscle conditions | 
| 02/20/2014 | US20140051708 Pyrazolyl-pyrimidine derivatives as kinase inhibitors | 
| 02/20/2014 | US20140051703 Thiopyrimidine-based compounds and uses thereof | 
| 02/20/2014 | US20140051681 Mst1 kinase inhibitors and methods of their use | 
| 02/20/2014 | US20140051680 Histone Deacetylase Inhibitors | 
| 02/20/2014 | US20140051679 Kinase inhibitors and method of treating cancer with same | 
| 02/20/2014 | US20140051675 Modulators of cellular adhesion | 
| 02/20/2014 | US20140051674 New compounds | 
| 02/20/2014 | US20140051672 1,4-disubstituted pyridazine analogs there of and methods for treating smn-deficiency-related conditions | 
| 02/20/2014 | US20140051665 Prostate cancer therapy with hsp90 inhibitory compounds | 
| 02/20/2014 | US20140051660 Cyclopentylpyrazoles as n-type calcium channel blockers | 
| 02/20/2014 | US20140051656 Antiviral compounds | 
| 02/20/2014 | DE102012016908A1 Tris-(Hetero)Aryl-Pyrazole und ihre Verwendung Tris (hetero) aryl pyrazoles and their use | 
| 02/19/2014 | EP2698368A1 Novel pyrazole derivative | 
| 02/19/2014 | EP2698367A1 Benzimidazoles for the treatment of cancer | 
| 02/19/2014 | EP2698062A1 Inhibitors of poly(adp-ribose)polymerase | 
| 02/19/2014 | EP2697216A1 Novel compounds for organic electronic material and organic electroluminescent device using the same | 
| 02/19/2014 | EP2697214A1 Substituted vinyl and alkinyl cyclohexenols as active agents against abiotic stress in plants | 
| 02/19/2014 | EP2697206A1 Heterocyclic compounds and uses thereof in the treatment of sexual disorders | 
| 02/19/2014 | EP2697197A1 Pyrrolo sulfonamide compounds for modulation of orphan nuclear receptor rar-related orphan receptor-gamma (rorgamma, nr1f3) activity and for the treatment of chronic inflammatory and autoimmune diseases | 
| 02/19/2014 | EP2696688A1 Use of substituted dithiine-dicarboximides for combating phytopathogenic fungi | 
| 02/19/2014 | CN103596943A Hydantoin derivates as Kv3 inhibitors | 
| 02/19/2014 | CN103596941A Anti-viral compounds | 
| 02/19/2014 | CN103596929A Pyrazolyl and pyrimidinyl tricyclic enones as antioxidant inflammation modulators | 
| 02/19/2014 | CN103596928A Neprilysin inhibitors | 
| 02/19/2014 | CN103588756A Preparation method of trityl olmesartan | 
| 02/19/2014 | CN103588718A Novel triazinedione derivatives as GABAB receptor modulators | 
| 02/19/2014 | CN102036983B Process for the preparation of 5-(2-amino-pyrimidin-4-yl)-2-aryl-1h-pyrrole-3-carboxamides | 
| 02/18/2014 | US8653262 CCR2 receptor antagonists and uses thereof | 
| 02/18/2014 | US8653127 Bicyclic pyrazolo-heterocycles | 
| 02/18/2014 | US8653112 Substituted pyrazoles as estrogen receptor ligands | 
| 02/18/2014 | US8653084 Hydrobenzamide derivatives as inhibitors of Hsp90 | 
| 02/18/2014 | US8653077 Inhibitors of human phosphatidylinositol 3-kinase delta | 
| 02/18/2014 | US8653070 Hepatitis C virus inhibitors | 
| 02/18/2014 | US8653062 Compounds as receptor modulators with therapeutic utility | 
| 02/18/2014 | US8652654 Biscarbazole derivative, material for organic electroluminescence device and organic electroluminescence device using the same | 
| 02/18/2014 | CA2743264C Tetrasubstituted pyridazines hedgehog pathway antagonists | 
| 02/18/2014 | CA2577061C Histamine h3 receptor agents, preparation and therapeutic uses | 
| 02/18/2014 | CA2564076C Chemical linkers and conjugates thereof | 
| 02/13/2014 | WO2014026009A2 Inhibition of antimicrobial targets with reduced potential for resistance | 
| 02/13/2014 | WO2014025976A1 Heteroaromatic compounds as bruton's tyrosine kinase (btk) inhibitors | 
| 02/13/2014 | WO2014025942A1 Nmda receptor modulators and uses related thereto | 
| 02/13/2014 | WO2014025850A1 Tricyclic amidine derivatives as hiv attachment inhibitors | 
| 02/13/2014 | WO2014025808A1 Curcumin analogs | 
| 02/13/2014 | WO2014025759A1 Iap antagonists | 
| 02/13/2014 | WO2014025128A1 N2,n4-bis(4-(piperazine-1-yl)phenyl)pirimidine-2,4-diamine derivative or pharmaceutically acceptable salt thereof, and composition containing same as active ingredient for preventing or treating cancer | 
| 02/13/2014 | WO2014024993A1 Piperazine derivative and use thereof | 
| 02/13/2014 | WO2014023723A1 Subtituted azines as pesticides | 
| 02/13/2014 | WO2014023691A1 Dihydroxypyrimidine carbonic acid derivatives and their use in the treatment, amelioration or prevention of a viral disease | 
| 02/13/2014 | WO2014023531A1 Trifluoromethylpyridine carboxamides as pesticides | 
| 02/13/2014 | WO2013190569A3 Novel salts of sunitinib and preparation thereof | 
| 02/13/2014 | US20140046053 Neprilysin inhibitors | 
| 02/13/2014 | US20140045910 Novel amino-pyrroline derivatives, and use thereof in the prevention and/or treatment of metabolic syndrome | 
| 02/13/2014 | US20140045862 Cycloalkane Derivatives | 
| 02/13/2014 | US20140045849 Pyrimidine derivatives for the treatment of viral infections | 
| 02/13/2014 | US20140045848 Thiopyrimidine-based compounds and uses thereof | 
| 02/13/2014 | US20140045845 Novel pyrimidine derivatives | 
| 02/13/2014 | US20140045838 Kinase inhibitors and method of treating cancer | 
| 02/13/2014 | US20140045822 Kinase inhibitors and method of treating cancer with same |